Mycology Immunoassays Testing Market

The frequency of invasive fungal infections has dramatically increased in the recent years and has high mortality and morbidity. Accurate and early diagnosis is very important for the appropriate antifungal therapy. Conventional techniques like microbiology, radiological and histological remain the basis of diagnosis but have limited impact on clinical decision making. There is always a need to characterize fungi accurately and quickly, which can be done by mycology immunoassays test. The fungi are parasitic and saprophytic eukaryotic organisms. The diagnostic methods for fungal infections are direct examination, radiology, and fungal culture and non-culture methods.

Mycology Immunoassays Testing Market contains market size and forecasts of Mycology Immunoassays Testing in Global, including the following market information:

• Global Mycology Immunoassays Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Mycology Immunoassays Testing market was valued at 1847.7 million in 2021 and is projected to reach US$ 2629.1 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ELISA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mycology Immunoassays Testing include Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioM?rieux, ELITechGroup, MiraVista Diagnostics and Autobio Diagnostics CO.,Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Mycology Immunoassays Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mycology Immunoassays Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mycology Immunoassays Testing Market Segment Percentages, by Type, 2021 (%)

• ELISA
• Rapid Tests
• ELISPOT
• Polymerase Chain Reaction (PCR)

Global Mycology Immunoassays Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mycology Immunoassays Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Blood Banks
• Others

Global Mycology Immunoassays Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mycology Immunoassays Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Mycology Immunoassays Testing revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Mycology Immunoassays Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Abbott
• Siemens
• Beckman Coulter
• Ortho-Clinical Diagnostics
• bioM?rieux
• ELITechGroup
• MiraVista Diagnostics
• Autobio Diagnostics CO.,Ltd.
• CapitalBio Corporation